BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21147213)

  • 41. Interferon-α suppresses cAMP to disarm human regulatory T cells.
    Bacher N; Raker V; Hofmann C; Graulich E; Schwenk M; Baumgrass R; Bopp T; Zechner U; Merten L; Becker C; Steinbrink K
    Cancer Res; 2013 Sep; 73(18):5647-56. PubMed ID: 23878189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.
    Horwitz DA; Pan S; Ou JN; Wang J; Chen M; Gray JD; Zheng SG
    Clin Immunol; 2013 Dec; 149(3):450-63. PubMed ID: 24211847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival.
    Zhang N; Krüger B; Lal G; Luan Y; Yadav A; Zang W; Grimm M; Waaga-Gasser AM; Murphy B; Bromberg JS; Schröppel B
    Immunol Lett; 2010 Jan; 127(2):119-25. PubMed ID: 19879295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.
    Blazar BR; Taylor PA; Snover DC; Sehgal SN; Vallera DA
    J Immunol; 1993 Nov; 151(10):5726-41. PubMed ID: 8228258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
    Han Y; Guo Q; Zhang M; Chen Z; Cao X
    J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
    Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
    PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease.
    Hannon M; Lechanteur C; Lucas S; Somja J; Seidel L; Belle L; Bruck F; Baudoux E; Giet O; Chantillon AM; Delvenne P; Drion P; Beguin Y; Humblet-Baron S; Baron F
    Transfusion; 2014 Feb; 54(2):353-63. PubMed ID: 23772685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low 17β-estradiol Levels Are Better Inducers of Regulatory Conditioned T Cells In-Vitro.
    Fatemi R; Mirzadegan E; Vahedian Z; Zarnani AH; Jeddi-Tehrani M; Idali F
    Iran J Immunol; 2017 Jun; 14(2):159-171. PubMed ID: 28630386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.
    Stenger EO; Rosborough BR; Mathews LR; Ma H; Mapara MY; Thomson AW; Turnquist HR
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):192-201. PubMed ID: 24239650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
    Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
    Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
    Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo.
    Vogtenhuber C; O'Shaughnessy MJ; Vignali DA; Blazar BR
    J Immunol; 2008 Dec; 181(12):8767-75. PubMed ID: 19050298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmentation of regulatory T cells in allergic individuals by recombinant Der f 2 peptide with fungal immunomodulatory peptide fve.
    Wu CC; Liao EC; Lee MF; Tsai JJ
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):216-22. PubMed ID: 19354068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
    Efimova OV; Kelley TW
    BMC Immunol; 2009 Nov; 10():59. PubMed ID: 19930596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.
    Zheng SG; Wang JH; Koss MN; Quismorio F; Gray JD; Horwitz DA
    J Immunol; 2004 Feb; 172(3):1531-9. PubMed ID: 14734731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates.
    Torrealba JR; Katayama M; Fechner JH; Jankowska-Gan E; Kusaka S; Xu Q; Schultz JM; Oberley TD; Hu H; Hamawy MM; Jonker M; Wubben J; Doxiadis G; Bontrop R; Burlingham WJ; Knechtle SJ
    J Immunol; 2004 May; 172(9):5753-64. PubMed ID: 15100322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
    Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
    J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.